What we offer today

Pharmacy-grade peptides, available now:

• GHK-Cu: nasal and topical

• Glutathione: injection and topical

• Gonadorelin: injection and nasal

• Oxytocin: nasal and sublingual

• Sermorelin: injection, nasal, and sublingual

• Semaglutide: injection and sublingual

• Tirzepatide: injection and sublingual

How we confirm quality:

• Verified ingredients from FDA-registered manufacturers
• Identity confirmed on every raw material lot
• Sterility and endotoxin testing on every sterile batch
• Validated potency and stability methods for extended dating
• Every preparation is pharmacist reviewed and quality-control verified

What's coming next

HHS released an interim policy on 10/28/2026 that opens a path for 503A pharmacies to compound six peptides. 

What the policy covers

Each peptide is covered only for the routes below, and each preparation contains a single active ingredient.

• BPC-157: Subcutaneous, intramuscular, oral, or topical
• TB-500: Subcutaneous or intramuscular injection
• KPV: Topical or oral
• MOTS-c: Subcutaneous or intramuscular injection
• Semax: Intranasal
• Epitalon: Subcutaneous or intramuscular injection, dispensed in intermittent courses
  

Here's what we're doing now to support your practice:

• Preparing our pharmacies. The path comes with conditions, and each pharmacy has to meet them before it compounds these peptides.
• Supporting your clinical questions. You get one-to-one guidance from our PharmD team.
• Building your peptide knowledge. Our Peptides 101 webinar and other tools and resources are available now on PharmAcademy.
• Keeping you current. Joining our early access list means you'll hear about regulatory changes and preparation availability directly from our team.